Trip has secured fresh investment from a slew of high-profile celebrities as it looks to fuel further growth domestically and overseas.
The CBD and wellness brand has raised £16.2m in new funding since a £10m Series A raise in 2022, filings at Companies House have shown.
The latest investments – made between February 2023 and last September – valued the rapidly growing Trip in excess of £100m.
Celebrities to have backed the brand include actress Blake Lively, reality TV star Millie Mackintosh, actor Paul Wesley and supermodel Ashley Graham.
Beauty, wellness and lifestyle specialist investment firm The Equity Studio – of which Victoria’s Secret model and actress Rosie Huntington-Whiteley is a partner – has also taken an undisclosed stake in the company.
Huntington-Whiteley’s business partner and The Equity Studio’s founder Anna Sweeting was appointed a director at Trip on 19 December last year.
Trip has now raised over £25m since its inception in 2019.
However, more than two-thirds of the company’s shares remain in the hands of its founding team, The Grocer understands.
The latest funding would be used to support Trip’s mission to become a “household name” in the UK, US and Europe, said co-founder Olivia Ferdi.
“We want to help a billion people find calm,” she said. “We’ve got big ambitions for the brand. We’ve grown really well across Europe, where the size of the functional market is $32bn now. Trip is leading that charge by changing the way that people drink.
“Our focus in 2025 is to build in the retailers that we are stocked with in the UK and online,” Ferdi continued. “In the US we have three supermarkets coming on board in Q1 which will take us to 3,500 doors and make us one of the best distributed UK brands in the US in the beverage space. We’re super excited to build on that momentum.”
Trip is yet to file full accounts at Companies House, but annual revenues are understood to be in excess of £20m.
Last April, it topped Alantra’s ‘Fast 50’ – a list of the fastest-growing businesses in UK food and drink – posting two-year compound annual sales growth (CAGR) of 389%.
No comments yet